share_log

There May Be Reason For Hope In PhiChem's (SZSE:300398) Disappointing Earnings

There May Be Reason For Hope In PhiChem's (SZSE:300398) Disappointing Earnings

PhiChem(深交所:300398)失望的盈利可能有希望的原因
Simply Wall St ·  09/05 18:33

Soft earnings didn't appear to concern PhiChem Corporation's (SZSE:300398) shareholders over the last week. We did some digging, and we believe the earnings are stronger than they seem.

上週飛凱材料(SZSE:300398)股東似乎並不關心利潤表的軟弱。我們進行了一些調查,我們相信利潤比它們看起來要強。

big
SZSE:300398 Earnings and Revenue History September 5th 2024
SZSE:300398 2024年9月5日業績和營收歷史

How Do Unusual Items Influence Profit?

非常規項目如何影響利潤?

Importantly, our data indicates that PhiChem's profit was reduced by CN¥65m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect PhiChem to produce a higher profit next year, all else being equal.

重要的是,我們的數據顯示,由於飛凱材料的異常項目,在過去一年中,利潤減少了6500萬元。看到異常項目給公司帶來的損失並不大好,但好消息是,事情可能很快會有所改善。我們研究了成千上萬家上市公司,發現異常項目很常見都是一次性的。考慮到這些項目被視爲異常,這一點幾乎是可以預料的。假設這些異常費用不會再次出現,其他情況保持不變的話,我們預計飛凱材料明年將會獲得更高的利潤。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓您想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看基於其估計的未來盈利能力的互動圖表。

Our Take On PhiChem's Profit Performance

對飛凱材料的利潤表現我們的看法

Unusual items (expenses) detracted from PhiChem's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that PhiChem's statutory profit actually understates its earnings potential! Unfortunately, though, its earnings per share actually fell back over the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Our analysis shows 3 warning signs for PhiChem (1 is a bit unpleasant!) and we strongly recommend you look at these before investing.

飛凡公司去年的非經常項目(開支)影響了收益,但我們可能會在明年看到改善。根據這一觀察,我們認爲飛凡公司的法定利潤實際上低估了其盈利潛力!不過,遺憾的是,過去一年其每股盈利實際上有所下滑。當然,在分析其收益時,我們只是觸及表面,還可以考慮利潤率、預測增長和投資回報率,以及其他因素。鑑於此,如果您希望對該公司進行更多分析,了解涉及的風險是至關重要的。我們的分析顯示飛凡公司存在3個警示信號(其中1個有點不太愉快!),我們強烈建議您在投資之前查看這些。

Today we've zoomed in on a single data point to better understand the nature of PhiChem's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

今天我們把焦點放在一個數據點上,以更好地了解飛凡公司的盈利性質。但如果您能夠專注於細枝末節,還有更多發現等着您。有些人認爲股東權益回報率高是優質業務的良好跡象。因此,您可能希望查看擁有高股東權益回報率的公司的免費收藏,或者擁有高內部持股的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論